| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―May―31 |
Altered lipid profile and lipoproteins in COVID-19 severity: A meta-analysis |
Hoimonti Debi, Rahima Begum, Zarin Tasnim Itu, Mohammad Tohidul Amin, Fahad Hussain, Md. Mamun Or Rashid, Mohammad Salim Hossain |
| 2 |
[GO] |
2025―Jan―10 |
Exploring abnormal hemostatic parameters and coagulopathy in a cohort of Egyptian patients with COVID-19 disease |
Mona Salah Eldin Hamdy, Manal Mohamed Makhlouf, Maha Hossam El-Din Ibrahim, Mohamed Tharwat Hegazy, Maha Hamdy Elsissy, Lamyaa Soliman, et al. (+6) Ghada Yousef Elkamah, Samah M. Mahdy, Hala Farawela, Mervat Matter, Rabab Khairat, Yehia Z. Gad |
| 3 |
[GO] |
2023―Feb―08 |
Evaluation of pooling strategy of SARS-CoV-2 RT-PCR in limited resources setting in Egypt at low prevalence |
Abeer Mohamed Abdelrazik, Manal Niazi El Said, Hossam M. Abdelaziz |
| 4 |
[GO] |
2023―Jan―17 |
Relation of ACE2 with co-morbidity factors in SARS-CoV-2 pathogenicity |
Dipannita Santra, Amrita Banerjee, Subrata Kr. De, Hrudayanath Thatoi, Smarajit Maiti |
| 5 |
[GO] |
2022―May―26 |
Comparative performance of CDC-modified SARS-CoV-2 real-time PCR assay with four different commercial assays: laboratory-based study |
Dayakar Seetha, Amjesh Ravikumar, Radhakrishnan R. Nair |
| 6 |
[GO] |
2022―Apr―28 |
Serosurvey for Middle East respiratory syndrome coronavirus antibody in dromedary camels and human patients at a secondary care hospital, Illela, Northwest Nigeria |
Samson Polycarp Salam, Grace Sabo Nok Kia, Faleke Olufemi Oladayo, Iniobong Chukwuebuka Ikenna Ugochukwu |
| 7 |
[GO] |
2022―Jan―13 |
Exosomes and COVID-19: challenges and opportunities |
Ghader Babaei, Nasrin Zare, Aynaz Mihanfar, Mohammad Hassan Khadem Ansari |
| 8 |
[GO] |
2021―Sep―10 |
Revealed pathophysiological mechanisms of crosslinking interaction of affected vital organs in COVID-19 |
Yousef Rasmi, Ghader Babaei, Muhammad Farrukh Nisar, Hina Noreen, Shiva Gholizadeh-Ghaleh Aziz |
| 9 |
[GO] |
2021―Jan―30 |
Critical roles of TLRs on the polarization of mesenchymal stem cells for cell therapy of viral infections: a notice for COVID-19 treatment |
Shiva Gholizadeh-Ghaleh Aziz, Shahriar Alipour, Parviz Ranjbarvan, Arezo Azari, Ghader Babaei, Ali Golchin |
